EF2_PICPA
ID EF2_PICPA Reviewed; 842 AA.
AC Q874B9;
DT 31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2003, sequence version 1.
DT 03-AUG-2022, entry version 84.
DE RecName: Full=Elongation factor 2;
DE Short=EF-2;
GN Name=EFT1; Synonyms=PEF1;
OS Komagataella pastoris (Yeast) (Pichia pastoris).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC Saccharomycetales; Phaffomycetaceae; Komagataella.
OX NCBI_TaxID=4922;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=12880776; DOI=10.1016/s1046-5928(03)00129-3;
RA Liu Y.Y., Woo J.H., Neville D.M. Jr.;
RT "Targeted introduction of a diphtheria toxin resistant mutation into the
RT chromosomal EF-2 locus of Pichia pastoris and expression of immunotoxin in
RT the EF-2 mutants.";
RL Protein Expr. Purif. 30:262-274(2003).
CC -!- FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step
CC during translation elongation. During this step, the ribosome changes
CC from the pre-translocational (PRE) to the post-translocational (POST)
CC state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound
CC deacylated tRNA move to the P and E sites, respectively. Catalyzes the
CC coordinated movement of the two tRNA molecules, the mRNA and
CC conformational changes in the ribosome (By similarity). {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC superfamily. Classic translation factor GTPase family. EF-G/EF-2
CC subfamily. {ECO:0000255|PROSITE-ProRule:PRU01059}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY219033; AAO39212.1; -; Genomic_DNA.
DR AlphaFoldDB; Q874B9; -.
DR SMR; Q874B9; -.
DR PRIDE; Q874B9; -.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR Gene3D; 3.30.230.10; -; 1.
DR Gene3D; 3.40.50.300; -; 1.
DR InterPro; IPR041095; EFG_II.
DR InterPro; IPR035647; EFG_III/V.
DR InterPro; IPR000640; EFG_V-like.
DR InterPro; IPR004161; EFTu-like_2.
DR InterPro; IPR031157; G_TR_CS.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR InterPro; IPR005225; Small_GTP-bd_dom.
DR InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR InterPro; IPR009000; Transl_B-barrel_sf.
DR InterPro; IPR005517; Transl_elong_EFG/EF2_IV.
DR Pfam; PF00679; EFG_C; 1.
DR Pfam; PF14492; EFG_III; 1.
DR Pfam; PF03764; EFG_IV; 1.
DR Pfam; PF00009; GTP_EFTU; 1.
DR Pfam; PF03144; GTP_EFTU_D2; 1.
DR PRINTS; PR00315; ELONGATNFCT.
DR SMART; SM00838; EFG_C; 1.
DR SMART; SM00889; EFG_IV; 1.
DR SUPFAM; SSF50447; SSF50447; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR SUPFAM; SSF54211; SSF54211; 1.
DR SUPFAM; SSF54980; SSF54980; 2.
DR TIGRFAMs; TIGR00231; small_GTP; 1.
DR PROSITE; PS00301; G_TR_1; 1.
DR PROSITE; PS51722; G_TR_2; 1.
PE 3: Inferred from homology;
KW Cytoplasm; Elongation factor; GTP-binding; Nucleotide-binding;
KW Protein biosynthesis.
FT CHAIN 1..842
FT /note="Elongation factor 2"
FT /id="PRO_0000091020"
FT DOMAIN 17..253
FT /note="tr-type G"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT BINDING 26..33
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 104..108
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 158..161
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT MOD_RES 699
FT /note="Diphthamide"
FT /evidence="ECO:0000250"
SQ SEQUENCE 842 AA; 93469 MW; BED5CF616E47F1A6 CRC64;
MVNFTVDQMR SLMDKVTNVR NMSVIAHVDH GKSTLTDSLV QRAGIISAAK AGEARFTDTR
KDEQERGITI KSTAISLYSE MGDDDVKEIK QKTEGNSFLI NLIDSPGHVD FSSEVTAALR
VTDGALVVVD CVEGVCVQTE TVLRQALGER IKPVVVINKV DRALLELQVT KEDLYQSFAR
TVESVNVVIA TYTDKTIGDN QVYPEQGTVA FGSGLHGWAF TVRQFATRYS KKFGVDRIKM
MERLWGDSYF NPKTKKWTNK DKDAAGKPLE RAFNMFVLDP IFRLFAAIMN FKKDEIPVLL
EKLEINLKRE EKELEGKALL KVVMRKFLPA ADALLEMIVL HLPSPVTAQA YRAETLYEGP
SDDQFCIGIR ECDPKAELMV YISKMVPTSD KGRFYAFGRV FSGTVKSGQK VRIQGPNYVP
GKKEDLFIKA VQRTVLMMGR TVEPIDDVPA GNILGIVGID QFLLKSGTLT TNEAAHNMKV
MKFSVSPVVQ VAVEVKNAND LPKLVEGLKR LSKSDPCVLT YISESGEHIV AGTGELHLEI
CLQDLQDDHA GVPLKISPPV VTYRETVTNE SSMTALSKSQ NKHNRIYLKA QPIDEELSLA
IEEGKVHPRD DFKARARIMA DEYGWDVTDA RKIWCFGPDG TGANLVVDQS KAVQYLHEIK
DSVVAGFQLA TKEGPILGEN MRSVRVNILD VTLHADAIHR GGGQVIPTMK RVTYAAFLLA
EPAIQEPIFL VEIQCPENAI GGIYSVLNKK RGQVISEEQR PGTPLFTVKA YLPVNESFGF
TGELRQATAG QAFPQMVFDH WANMNGNPLD PASKVGEIVL AARKRQGMKE NVPGYEEYYD
KL